Sunwin deal increases stevia capacity
This article was originally published in The Tan Sheet
Executive Summary
Qufu, China-based Sunwin International Nutraceuticals acquires Qufu Shengren Pharmaceutical Co., a manufacturing facility that will be retrofitted to produce stevia, according to an April 8 announcement. The $3 million deal, made through Sunwin's subsidiary Qufu Natural Green Engineering Co., will increase the firm's stevia production capacity to 250 tons annually, said Sunwin Chairman Laiwang Zhang in the release. Sunwin's U.S. subsidiary sells stevia-based OnlySweet as a dietary supplement in the U.SYou may also be interested in...
Novartis And The Medicines Company: Five Things To Worry About
The $9.7bn acquisition hinges on the small interfering RNA inclisiran, but an ongoing cardiovascular outcomes trial, manufacturing hurdles, and reimbursement challenges provide subjects for concern.
QUOTED. 12 December 2019. Scott Whitaker
US congressional leaders and medtech industry advocacy group AdvaMed are giving their full-throated endorsement to a US-Mexico-Canada (USMCA) trade agreement announced by the US Trade Representative's Office on 10 December. See what AdvaMed's president and CEO, Scott Whitaker, said about it in a statement here.
Horizon Teprotumumab's US Advisory Cmte. Likely To Focus On Labeling, Not Approval, Questions
FDA seems poised to approve the drug for the orphan eye disease called TED, but remains concerned about labeling for some adverse events.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: